Efficacy of L-methylfolate and Methylcobalamine in Treating Resistant Hypertension Associated with Elevated Serum Homocysteine in Hemodialysis Patients.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions

End Stage Renal DiseaseHypertension, Renal

Interventions

DRUG

L-Methyl Folate and methylcobalamine

Dietary supplement labeled to contain methylfolate 800 micrograms and methylcobalamine 1000 micrograms

Trial Locations (1)

Faculty of Pharmacy, Alexandria University, Alexandria

All Listed Sponsors

lead

Alexandria University

OTHER